Back

ARTISAN: Afterload Reduction To Improve Right Ventricular Structure And FuNction

29 August 2026 (12:00 - 12:15)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Science: pulmonary hypertension Pulmonary Hypertension ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Irene Marthe Lang

Medical University of Vienna, Vienna (Austria)

4 More presentations in this session

Presentation thumbnail
Treatment with Ralinepag Improves Outcomes in Patients with Connective Tissue Disease Associated with Pulmonary Arterial Hypertension: Results from the Phase 3 ADVANCE Outcomes Study
Professor G. Giannakoulas (Thessaloniki, GR)
Slides Video
Presentation thumbnail
Levosimendan in patients with pulmonary hypertension due to heart failure with preserved ejection fraction: results of the LEVEL trial
Professor S. Shah (Chicago, US)
Video
Presentation thumbnail
Automated Detection of Pulmonary Hypertension from a Single Apical Four-Chamber Echocardiographic Clip: development on the largest RHC-confirmed cohort to date and multinational external validation
Doctor F. Alenezi (Durham, US)
Slides Video
Presentation thumbnail
Pulmonary Arterial Hypertension in Families with Hereditary Hemorrhagic Telangiectasia: A Nationwide Family Registry
Doctor Y. Zhou (Guangzhou, CN)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Clinical Science: pulmonary hypertension
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 12:00 CET
You may be interested in
thumbnail
Congress Session
Molecular approaches to the treatment of pulmonary hypertension
27 August 2023
thumbnail
Congress Presentation
Echocardiographic assessment for responder analysis in pulmonary arterial hypertension patients treated with parenteral prostanoids
31 August 2025
thumbnail
Congress Presentation
Outcomes following transcatheter tricuspid valve intervention
28 August 2026
thumbnail
Congress Presentation
Safety and efficacy of macitentan and riociguat upfront combination therapy in patients with idiopathic pulmonary arterial hypertension at intermediate risk.
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources